169321 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
Endogenous Labelling of Extracellular Vesicles
#302Method for detecting castration-resistant prostate cancer and detection reagent
#303Assessment of preeclampsia using assays for free and dissociated placental growth factor
#304Inhibition of cytokine-induced SH2 protein in NK cells
#305HUMAN ANTIBODY SPECIFIC FOR INTERLEUKIN-1ALPHA
#306REFRACTORY ASTHMA PROPHYLACTIC/THERAPEUTIC AGENT SCREENING METHOD, AND REFRACTORY ASTHMA PROPHYLACTIC/THERAPEUTIC AGENT
#307Methods of Detecting and Preventing Atopic Allergic Diseases
#308System and method for removal of immune inhibitors from biological fluids
#309SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#310MECHANISM OF ACTION
#311Method of determining toxicity of an immunomodulatory drug for use in humans
#312ANTIBODY
#313Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers
#314Egg, fertilized egg, or embryo quality improving agent
#315Method of identifying potential inhibitors of APO TNFα trimers
#316Anti-GM-CSF antibodies and uses thereof
#317BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND CANCER
#318ASSAY PANELS
#319METHODS AND COMPOSITIONS FOR TREATING VITILIGO
#320Antibodies and assays for CCL14
#321Methods and compositions for the treatment of an inflammatory bowel disease
#322METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#323METHOD AND KIT FOR ASSISTING DIAGNOSIS OF DISEASE IN SUBJECT
#324METHOD OF PREDICTING AND DETERMINING THERAPEUTIC EFFECT ON RHEUMATOID ARTHRITIS DUE TO BIOLOGICAL FORMULATION
#325DIAGNOSIS FOR VARIOUS DISEASES USING TUMOR MICROENVIRONMENT ACTIVE PROTEINS
#326Methods and Compositions for Modulating TH-GM Cell Function
#327MICROFLUIDIC CHIP, MICROFLUIDIC LAB-ON-CHIP, FABRICATION METHOD OF ONE SUCH CHIP AND ANALYSIS METHOD
#328Method for quantitatively determining a therapeutic TNF-alpha inhibitor
#329Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors
#330METHODS FOR DECONTAMINATING CIRCUITS FOR PRODUCING GLUCOSE POLYMERS AND HYDROLYSATES OF GLUCOSE POLYMERS
#331Anti-CXCL13 antibodies
#332METHOD FOR DETERMINING DYSBIOSIS IN THE INTESTINAL MICROBIOME
#333BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES
#334Ratios of sFlt-1 to P1GF or endoglin to P1GF as biomarkers for preeclampsia related adverse outcomes after birth
#335DETECTING CYTOKINE SIGNALING RESPONSIVENESS IN IMMUNE CELLS
#336BIOMARKERS USEFUL IN THE TREATMENT OF IL-23A RELATED DISEASES
#337METHOD FOR DETERMINING A TISSUE INJURY AND REPAIR (TIAR) PROCESS ASSOCIATED WITH ABNORMAL FORMATION OF ENDOMETRIAL TISSUE
#338Device and method for detection of analytes
#339METHODS AND KITS FOR ANALYSIS OF HMGB1 ISOFORMS
#340Minimally-invasive measurement of esophageal inflammation
#341Biomarkers for vitiligo
#342Method for measuring a biomarker in a biological sample of an IPAF patient
#343TARGETED CYTOKINE BLOCKADES FOR CAR-T THERAPY
#344Methods of administering anti-OX40 antibodies
#345METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#346Method for determining sensitivity of cyclin-dependent kinase 4/6 inhibitor
#347OPTIMIZED METHOD FOR DECONTAMINATING PRODUCTION OF GLUCOSE POLYMERS AND GLUCOSE POLYMER HYDROLYZATES
#348ANTI-INFLAMMATORY COMPOSITIONS, METHODS AND USES THEREOF
#349Biomarkers related to organ function
#350Methods and materials for assessing and treating cancer
#351Vectors comprising nucleic acids encoding anti-OX40 antibodies
#352CCL20 as a predictor of clinical response to IL23-antagonists
#353Apparatus and methods for monitoring of biomarkers in blood
#354AGENT FOR CONTROLLING CELLS CONSTITUTING CANCER MICROENVIRONMENT OR INFLAMMATORY MICROENVIRONMENT
#355THERAPY AND DIAGNOSTICS
#356Monitoring inflammation status
#357Method of enriching a target nucleic acid at a TNFRSF1B gene locus in a sample from a subject with inflammatory bowel disease
#358Antibodies specific for sclerostin and methods for increasing bone mineralization
#359Biomarkers in autoimmune liver disease
#360Signature of TL1A (TNFSF15) signaling pathway
#361BIOMARKERS FOR WOUND HEALING
#362Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
#363DETECTION OF CHO-MIF CONTAMINATIONS
#364GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients
#365METHOD FOR PREVENTING OR TREATING ATHEROSCLEROSIS
#366PEPTIDES FOR USE IN TREATMENT AND DIAGNOSIS OF TYPE 1 DIABETES
#367Potency assay
#368Antibodies targeting b-cell maturation antigen and methods of use
#369Use of anti-FAM19A5 antibodies for treating fibrosis
#370Peptide Libraries and Methods of Use
#371METHODS FOR DIAGNOSING AND TREATING CACHEXIA
#372Microdroplet based bioassay platform
#373Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
#374ANTIBODIES TO IL-6 AND USE THEREOF
#375BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#376ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP
#377Signatures and determinants for diagnosing infections and methods of use thereof
#378Methods of analysis of blood from deceased donors
#379T CELL BALANCE GENE EXPRESSION, COMPOSITIONS OF MATTERS AND METHODS OF USE THEREOF
#380Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer
#381Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
#382ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF
#383Methods of diagnosing and predicting renal disease
#384Materials and methods for subjects at risk for viral reactivation
#385SYSTEM AND METHODS FOR DIAGNOSING ACUTE INTERSTITIAL NEPHRITIS
#386METHOD FOR DIAGNOSING AND TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER
#387METHODS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#388Application of PDCD4 as a therapeutic target for antidepressants and/or anxiolytics drugs
#389Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
#390COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#391METHODS FOR DOSING AND MONITORING SMAD7 ANTISENSE OLIGONUCLEOTIDE TREATMENT USING BIOMARKER LEVELS
#392Method of detecting the presence of complement C5
#393USE OF HLA GENETIC STATUS TO ASSESS OR SELECT TREATMENT OF CELIAC DISEASE
#394COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#395Isolated B7-H4 specific compositions and methods of use thereof
#396Atomic description of immune complex that causes heparin-induced thrombocytopenia
#397PULMONARY HYPERTENSION BIOMARKER
#398Pumpless microfluidic organ-on-a-chip system including a functional immune system
#399DIAGNOSTIC AND SCREENING METHODS FOR ATOPIC DERMATITIS
#400Disulfide-type HMGB1-specific antibody, method for measuring disulfide-type HMGB1 and kit for said measurement, and measurement method capable of quantitating all of HMGB1 molecules including reduced HMGB1, disulfide-type HMGB1 and thrombin-cleavable HMGB1 and kit for said measurement
#401VALIDATION OF NEOEPITOPE-BASED TREATMENT
#402CHIMERIC RECEPTORS, BIOSENSOR HOST CELLS AND METHODS/USES THEREOF
#403S-layer protein 2D lattice coupled detergent-free GPCR bioelectronic interfaces, devices, and methods for the use thereof
#404Nucleic acids encoding anti-OX40 antibodies
#405Methods for modulating signal intensity in interaction assays
#406Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
#407CHARACTERISTIC ANALYSIS METHOD AND CLASSIFICATION OF PHARMACEUTICAL COMPONENTS BY USING TRANSCRIPTOMES
#408Method of Identifying Transmembrane Protein-interacting Compounds
#409Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens
#410MATERIAL AND METHODS FOR DIAGNOSING AND TREATING KAWASAKI DISEASE AND KLS
#411Anti-OX40 antibodies
#412Methods and compositions related to toxicity associated with cell therapy
#413Methods of prognosis and treatment
#414Early diagnosis of infections
#415Methods of risk assessment and disease classification for appendicitis
#416PREDICTIVE BIOMARKERS OF CLINICAL RESPONSE TO ANTI-LPS IMMUNOGLOBULIN TREATMENT
#417COMPOSITIONS AND METHODS FOR DIAGNOSING CELIAC DISEASE USING CIRCULATING CYTOKINES/CHEMOKINES
#418Method for predicting severity and prognosis of cardiovascular disease
#419Elevated CCL19 after completion of therapy for acute lyme disease identifies patients at risk for development of post-treatment lyme disease syndrome who will benefit from further antibiotic therapy
#420Screening assay for choice of prebiotic to prevent/treat gastrointestinal and systemic diseases
#421Anti-CTLA4 antibodies
#422Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a human sample
#423COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#424Cytokine profiling analysis
#425METHODS AND DEVICES FOR STORING OR STABILIZING MOLECULES
#426Method of treatment of breast or colon cancer by administering muscle stimulated myokines
#427Anti-IL17A autoantibodies for treating or reducing the likelihood of occurrence of bone destruction associated with a chronic autoimmune or inflammatory disease
#428Therapeutically triggering an innate immune response in a target tissue
#429Method for identifying a bacterial infection
#430Protein signatures for distinguishing between bacterial and viral infections
#431Chemically patterned microfluidic paper-based analytical device (C-μPAD) for multiplex analyte detection
#432Methods for detecting, diagnosing and treating ulcerative interstitial cystitis
#433MICROFLUIDIC DETERMINATION OF IMMUNE AND OTHER CELLS
#434BIOMARKERS
#435KIT FOR PREDICTING IMPLANTATION SUCCESS IN ASSISTED FERTILIZATION
#436Detection and quantification of AKT-mTOR pathway proteins
#437Method of monitoring the efficacy of the anti-clever-1 therapy in cancer
#438Antibody facilitating programmed necrosis of cells and application thereof
#439Nucleic acids encoding anti-C5 antibodies
#440Methods of treating intestinal fibrosis using SMAD7 inhibition
#441METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#442Vagus nerve stimulation pre-screening test
#443Biomarker signatures for lyme disease differentiation and methods of use thereof
#444Method for detecting analyte concentration
#445IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy
#446Signatures and determinants for diagnosing infections and methods of use thereof
#447Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers
#448Anti-GM-CSF antibodies and uses thereof
#449METHOD FOR PREDICTING THERAPEUTIC EFFECT OF BIOLOGICAL PREPARATION ON RHEUMATOID ARTHRITIS
#450Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
#451Anti-GM-CSF antibodies and uses thereof
#452REGULATION OF CYTOKINE PRODUCTION
#453Flow cytometry system and methods for the diagnosis of infectious disease
#454Binding-triggered transcriptional switches and methods of use thereof
#455ERYTHROFERRONE AND ERFE POLYPEPTIDES AND METHODS OF REGULATING IRON METABOLISM
#456Method for diagnosing and treating fibromyalgia
#457METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC INFLAMMATORY DISEASES
#458Minimally-invasive measurement of esophageal inflammation
#459Identification of Biomarkers in Serum Samples Collected from Clinical Trials by Multiplex Technology
#460Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)
#461Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes
#462Compositions and methods to detect non-coeliac gluten sensitivity
#463SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR THE ORGANISM-SPECIFIC DIAGNOSIS OF SEPTICEMIA IN INFANTS
#464Nucleic acids encoding anti-Factor P antibodies
#465Anti-nodal antibodies and methods of using same
#466CONSTRUCTION METHOD OF CELL MODELS FOR DETECTING PYROGENS, CELL MODELS AND PYROGEN DETECTION KITS
#467WATER SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF
#468PROGNOSIS AND TREATMENT OF SQUAMOUS CELL CARCINOMAS
#469Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel disease
#470Therapeutic immune modulation using noble gas compositions
#471Inhibition of cytokine-induced SH2 protein in NK cells
#472Anti-nodal antibodies and methods of using same
#473Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate
#474Device and method for detection of analytes
#475Substrate, structure, structure-manufacturing method, cell-sorting method, cell-manufacturing method, and secretion-producing method
#476Biomarkers for assessing subjects with multiple sclerosis
#477Tumor necrosis factor 1B (TNF-1B) mutants and methods of use thereof to screen for candidate therapeutic compounds
#478Immunological signatures and parameters predicting therapeutic responses to anti-TNF therapy
#479Method of Identifying Transmembrane Protein-interacting Compounds
#480(EN) POTENTIATED T-CELL MODULATOR ABLE TO MODULATE IMMUNE RESPONSE, METHOD FOR EXTRACTING, TESTING AND COUNTING A DIALYSABLE LEUCOCYTE EXTRACT FROM SHARK SPLEEN TO PRODUCE SAME, AND THERAPEUTIC USE THEREOF
#481Biomarkers predictive of cytokine release syndrome
#482IMMUNOLOGICAL TEST METHOD AND IMMUNOLOGICAL TEST KIT
#483Method for predicting prognosis of patient with cancer or inflammatory disease
#484Tools and methods for expression of membrane proteins
#485Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers
#486METHOD OF PREDICTING AND DETERMINING THERAPEUTIC EFFECT ON RHEUMATOID ARTHRITIS DUE TO BIOLOGICAL FORMULATION
#487Method for the selection of antibodies against BCMA
#488Polypeptide having chemokine activity and uses thereof
#489Detection of CHO-MIF contaminations
#490Mesenchymal stem cells with enhanced efficacy in treatment of autoimmunity particularly rheumatoid arthritis
#491Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#492Binding-triggered transcriptional switches and methods of use thereof
#493Methods of identifying signaling modulators of the trimeric TNFa
#494Microdroplet based bioassay platform
#495Human T cell line assay for evaluating the immunologic identity of glatiramer acetate preparations
#496PREVENTION OF METASTASIS AND RECURRENCE AFTER PRIMARY CANCER TREATMENT
#497Methods for treating inflammatory bowel disease
#498Future cardiac event biomarkers CCL3, CCL5, and CCL18
#499TNF receptor signaling modulator assay
#500Antibodies binding to trimeric TNF alpha epitopes
#501Method of Assessing Infection Status
#502Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them
#503Prostate cancer-associated secreted proteins
#504BIOLOGICAL SPECIMEN EVALUATION METHODS USING CYTOLOGY AND IMMUNOLOGY
#505NOVEL DESIGN OF ENZYME-LINKED IMMUNOSORBENT ASSAY PLATES AND SYSTEMS AND METHODS OF USE THEREOF
#506Human antibody specific for interleukin-1 alpha
#507CXCL13 AS AN INDICATOR OF GERMINAL ACTIVITY AND IMMUNE RESPONSE
#508BIOMARKER FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS
#509Antibodies targeting B-cell maturation antigen and methods of use
#510Light detection system and method of using same
#511METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#512Method for Discriminating Symptom of Hepatic Disease
#513Diagnostic and screening methods for atopic dermatitis
#514Combination immune therapy and cytokine control therapy for cancer treatment
#515Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides
#516Method of treating allergic asthma with antibodies to IL-6
#517Kit for predicting implantation success in assisted fertilization
#518Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment
#519Binding-triggered transcriptional switches and methods of use thereof
#520USE OF RANK/RANKL ANTAGONISTS FOR TREATING NEUROMUSCULAR DISORDERS, GENETIC MYOPATHIES AND/OR NON GENETIC MYOPATHIES AND/OR FOR REGULATING SKELETAL AND CARDIAC MUSCLE DISUSE, DISEASES AND AGING
#521IDENTIFICATION, MONITORING AND TREATMENT OF INFECTIOUS DISEASE AND CHARACTERIZATION OF INFLAMMATORY CONDITIONS RELATED TO INFECTIOUS DISEASE USING GENE EXPRESSION PROFILES
#522DIAGNOSTIC AND THERAPEUTIC EPITOPE, AND TRANSGENIC PLANT
#523TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF
#524ASSAY PANELS
#525METHOD AND DEVICE FOR DETECTING IN REAL TIME A SECRETED COMPOUND AND THE SECRETION TARGET, AND USES THEREOF
#526Antagonists of IL-6 to raise albumin and/or lower CRP
#527Compositions and methods for expressing polypeptides on the surface of cells
#528Human CDR-grafted antibody and antibody fragment thereof
#529Atomic description of immune complex that causes heparin-induced thrombocytopenia
#530Methods for evaluation of the effectiveness of a drug or drug candidate in treating an inflammatory bowel disease by use of multiplexed assay kit comprising various biomarkers
#531Methods for treating or preventing asthma by administering an IL-4R antagonist
#532Methods and compositions in diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis
#533Methods of diagnosing and predicting renal disease
#534METHODS AND KITS FOR ANALYSIS OF HMGB1 ISOFORMS
#535Universal assay for determining the quantity of TNFα inhibitory drugs and their corresponding anti-drug-antibodies
#536Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
#537Methods of neutralizing C5 with anti-C5 antibodies
#538Agent for controlling cells constituting cancer microenvironment or inflammatory microenvironment
#539METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF STROKE OR OTHER CEREBRAL INJURY
#540Methods for non-invasive profiling of stem cell differentiation
#541Method of Identifying Transmembrane Protein-interacting Compounds
#542PIF BINDING AS A MARKER FOR IMMUNE DYSREGULATION
#543TARGET PEPTIDES FOR IMMUNOTHERAPY AND DIAGNOSTICS
#544BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#545ASSAY SYSTEMS FOR POINT OF CARE DETECTION OF OCULAR ANALYTES
#546BISPECIFIC ANTIBODIES AGAINST CD3 EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES
#547METHODS OF TREATING MYELODYSPLASTIC SYNDROME WITH FARNESYLTRANSFERASE INHIBITORS
#548Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
#549METHOD OF DIAGNOSING AND TREATING BRAIN ENDOTHELIAL INFLAMMATION RELATED DISEASE
#550METHODS FOR IDENTIFICATION AND PREDICTION OF MULTIPLE SCLEROSIS DISEASE AND THERAPY RESPONSE
#551Peptides for diagnosis and treatment of cancer
#552METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#553SYSTEM FOR ASSESSING DRUG EFFICACY AND RESPONSE OF A PATIENT TO THERAPY
#554ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS
#555Biomarkers and assay to detect chronic graft versus host disease
#556METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#557Epidermal Growth Factor Receptor (EGFR) Protein SRM Assay
#558Soluble engineered monomeric Fc
#559METHODS FOR DOSING AND MONITORING SMAD7 ANTISENSE OLIGONUCLEOTIDE TREATMENT USING BIOMARKER LEVELS
#560METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#561Dual Variable Domain Immunoglobulins and Uses Thereof
#562METHODS FOR PREDICTING CLINICAL OUTCOMES IN SUBJECTS AFFLICTED WITH ULCERATIVE COLITIS
#563Methods and compositions for modulating T-GM cell function
#564Use of HLA genetic status to assess or select treatment of celiac disease
#565MONOVALENT BINDING PROTEINS
#566HUMAN-DERIVED ANTI-HUMAN IL-20 ANTIBODIES AND ASSAY FOR THE IDENTIFICATION OF ANTI-CYTOKINE ANTIBODIES
#567Human exhaled aerosol droplet biomarker system and method
#568Screening assay for choice of prebiotic to prevent/treat gastrointestinal and systemic diseases
#569Methods for treating medical conditions by anti-type 2 therapy
#570Methods of detecting and preventing atopic allergic diseases
#571Plasmonic substrates for metal-enhanced fluorescence based sensing, imaging and assays for cells
#572Biomarkers useful in the treatment of IL-23A related diseases
#573Diagnosis and treatment of Kawasaki disease
#574Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
#575INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#576VACCINES AND MONOCLONAL ANTIBODIES TARGETING TRUNCATED VARIANTS OF OSTEOPONTIN AND USES THEREOF
#577Transgenic mouse expressing kidney-specific human TGF-beta1, and biomarker for tissue fibrosis mouse model
#578METHODS AND DEVICES FOR DIAGNOSING OCULAR SURFACE INFLAMMATION AND DRY EYE DISEASE
#579Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer
#580Devices and methods for the rapid and accurate detection of analytes
#581METHODS FOR ASSESSING THE EFFICACY OF ANTI-INFLAMMATORY CYTOKINE COMPOSITIONS
#582Two-dimensional material-based field-effect transistor sensors
#583Method for diagnosing fibromyalgia syndrome, and kit therefor
#584Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast
#585PULMONARY HYPERTENSION BIOMARKER
#586NOVEL CRYSTAL STRUCTURE AND LIGAND BINDING SITES OF TRAIL RECEPTOR
#587Biological dosage of peptidoglycans
#588Minimally-invasive measurement of esophageal inflammation
#589Methods for determining susceptibility to coreceptor inhibitors
#590INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#591METHODS FOR DIAGNOSING CELIAC DISEASE USING CIRCULATING CYTOKINES/CHEMOKINES
#592METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#593Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
#594METHODS OF MEASURING ANTIGEN-SPECIFIC T CELLS
#595METHODS OF DIAGNOSING CELIAC DISEASE USING IP-10
#596ELISA for a Naturally-Occurring Soluble Truncated Form of IL-23 Receptor
#597Compositions and methods relating to Lyme disease
#598Signatures and determinants for diagnosing infections and methods of use thereof
#599Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of
#600Atypical hemolytic uremic syndrome (aHUS) biomarker proteins